Proqr Therapeutics (PRQR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2015 | 12-2014 | 12-2013 | 12-2006 | |
| Assets | ||||
| Current Assets | ||||
| Cash & Cash Equivalents | 105,338 | 149,860 | N/A | N/A |
| Receivables | 607 | 0 | N/A | N/A |
| Other current assets | 1,062 | 1,540 | 0 | 0 |
| TOTAL | $108,563 | $151,400 | $N/A | $N/A |
| Non-Current Assets | ||||
| PPE Net | 2,442 | 1,570 | N/A | N/A |
| Intangibles | 157 | 0 | 0 | 0 |
| Other Non-Current Assets | 0 | 210 | 0 | 0 |
| TOTAL | $2,598 | $1,780 | $N/A | $N/A |
| Total Assets | $111,161 | $153,190 | $N/A | $N/A |
| Liabilities | ||||
| Current Liabilities | ||||
| Accounts payable and accrued liabilities | 983 | 1,650 | 0 | 0 |
| Other current liabilities | 4,949 | 2,300 | N/A | N/A |
| TOTAL | $6,092 | $4,000 | $N/A | $N/A |
| Non-Current Liabilities | ||||
| Long Term Debt | 5,357 | 3,740 | N/A | N/A |
| Deferred Revenues | 160 | N/A | N/A | N/A |
| TOTAL | $5,357 | $3,760 | $N/A | $N/A |
| Total Liabilities | $11,448 | $7,760 | $N/A | $N/A |
| Shareholders' Equity | ||||
| Shares Outstanding, K | N/A | N/A | 20,963 | N/A |
| Common Shares | 1,037 | 1,240 | N/A | N/A |
| Retained earnings | -40,674 | -21,000 | N/A | N/A |
| Other shareholders' equity | 2,110 | 920 | 0 | 0 |
| TOTAL | $99,713 | $145,430 | $N/A | $N/A |
| Total Liabilities And Equity | $111,161 | $153,190 | $0 | $0 |